| Literature DB >> 31495555 |
Laure Peyro-Saint-Paul1, Nathalie Derache2, Maxence Ficheux3, Stéphane Allouche4, Jean-Jacques Parienti5, Floriane Calocer2, Florian Le Caignec5, Sophie Fedrizzi6, Gilles Defer2.
Abstract
Entities:
Keywords: Adverse reaction; Bone pain; Multiple sclerosis; Safety; Teriflunomide
Mesh:
Substances:
Year: 2019 PMID: 31495555 DOI: 10.1016/j.therap.2019.07.006
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070